Cargando…
Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients
BACKGROUND: Butyrylcholinesterase (BChE) is synthesized mainly in the liver and an important marker in many infectious/inflammatory diseases, but its role in acquired immunodeficiency syndrome (AIDS) patients is not clear. We wished to ascertain if BChE level is associated with the progression/progn...
Autores principales: | Xu, Lijun, Zhu, Biao, Huang, Ying, Yang, Zongxing, Sun, Jia, Xu, Yan, Zheng, Jinlei, Kinloch, Sabine, Yin, Michael T., Weng, Honglei, Wu, Nanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875035/ https://www.ncbi.nlm.nih.gov/pubmed/29736152 http://dx.doi.org/10.1155/2018/5201652 |
Ejemplares similares
-
Identification of Compounds for Butyrylcholinesterase Inhibition
por: Li, Shuaizhang, et al.
Publicado: (2021) -
Does serum butyrylcholinesterase level determine the severity and mortality of COVID-19 pneumonia?: Prospective study
por: Sipahioglu, Hilal, et al.
Publicado: (2022) -
Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011) -
Moderate/Severe Hyponatremia Increases the Risk of Death among Hospitalized Chinese Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients
por: Xu, Lijun, et al.
Publicado: (2014) -
Butyrylcholinesterase Predicts Cardiac Mortality in Young Patients with Acute Coronary Syndrome
por: Sulzgruber, Patrick, et al.
Publicado: (2015)